BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 2, 2007
View Archived Issues
Recent Dainippon Sumitomo patent discloses novel treatment option for glaucoma
Read More
New therapeutic agents for neurological disorders reported in recent patent literature
Read More
Recent patents impart novel agents for treating hematological disorders
Read More
Cetuximab in gastrointestinal cancers: snapshots of clinical trials
Read More
Novel andrographolide analogue DRF-3173 decreases body weight in hyperlipidemic mice
Read More
Australian organizations establish cooperative cancer research center
Read More
PBI-1393 for cervical cancer completes preclinical toxicology studies
Read More
NovoLog approved for pregnancy Category B rating
Read More
End-of-phase II meeting for Diamyd
Read More
FDA awards orphan drug status to Gestiva for prevention of preterm birth
Read More
DSMB stops phase III trial of tesmilifene in advanced breast cancer
Read More
AstraZeneca and Palatin collaborate in obesity
Read More
Oral azacitidine cleared to begin phase I study
Read More
Argenta and AstraZeneca collaborate on bronchodilators for COPD
Read More
Phase II study of Ushercell for HIV prevention halted early
Read More
Cellzome research program with OrthoMcNeil extended
Read More
FDA accepts IND for phase III study of Glypromate
Read More
Enrollment target reached in phase II study of MD-05 in dental implantology
Read More
Systemic small molecule Hedgehog antagonist begins phase I testing
Read More
Novel glycine reuptake inhibitor may be useful to treat alcoholism
Read More
Santhera brings forward timelines for idebenone development in Friedreich's ataxia
Read More
ATG-3 completes phase I study for wet AMD
Read More
FDA Advisory Committee date set for orBec review in GI GVHD
Read More
Molecularly targeted anti-EGFR antibody eradicates NSCLC tumors in mice
Read More
New phase I/II trial explores AGS-005 in B-cell CLL
Read More
GX15-070 begins new trials in NSCLC and mantle cell lymphoma
Read More